从成纤维细胞灶到致密瘢痕:PAK2激活的成纤维细胞驱动特发性肺纤维化进展
本文为针对Watanabe等研究的通信评论,聚焦特发性肺纤维化(IPF)中成纤维细胞灶(FF)与致密纤维化(DF)区域的成纤维细胞亚群。研究通过空间与单细胞转录组整合分析,识别PAK2为FF及周边区域激活的关键促纤维化激酶,并显示抑制PAK2可减轻小鼠模型纤维化,提示其作为抗纤维化靶点的潜力。
要点
- WNT5A+CTHRC1+肌成纤维细胞驱动IPF成纤维细胞灶与致密纤维化区域纤维化。
- PAK2在成纤维细胞灶及周边区域激活,抑制PAK2可减轻小鼠模型纤维化。
- PAK2被视为IPF潜在抗纤维化治疗靶点。
核心结论
- WNT5A+CTHRC1+肌成纤维细胞驱动IPF成纤维细胞灶与致密纤维化区域的纤维化。
- PAK2在这些细胞中激活并促进疾病,抑制PAK2提供有前景的抗纤维化策略。
研究设计与样本
- 通信评论,评述Watanabe等结合空间与单细胞转录组分析IPF成纤维细胞灶与致密纤维化区域的研究。
主要发现
- 研究识别PAK2为成纤维细胞灶及周边区域激活的关键促纤维化激酶。
- 抑制PAK2可减轻小鼠模型中的纤维化。
临床怎么用
- 提示PAK2可能作为IPF抗纤维化治疗的潜在靶点,尚需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
WNT5A+CTHRC1+ myofibroblasts drive fibrosis in both fibroblastic foci and dense fibrosis regions in IPF. PAK2 activation in these cells promotes disease, and its inhibition offers a promising antifibrotic strategy. https://bit.ly/45rA6fo Fibrotic diseases contribute to nearly 45% of all deaths in the developed world, affecting vital organs such as the lungs, liver, heart and kidneys. Transforming growth factor (TGF)-β is a central driver of fibrosis, promoting the activation of fibroblasts into myofibroblasts and the excessive deposition of extracellular matrix [1]. The cell-type-specific activation of p21-activated kinase 2 (PAK2) in TGF-β signalling has been recognised for some time [2, 3], but its role in fibrotic diseases has only recently come to light [4]. With great interest, we read the recent article by Watanabe et al. [5], describing a novel cellular mechanism by which PAK2 may drive fibrotic remodelling and its implication for potential therapeutic targeting in idiopathic pulmonary fibrosis (IPF). This study offers valuable insights into the distinct fibroblast populations within fibroblastic foci (FF) and dense fibrosis (DF) regions of IPF through integrated spatial and single-cell transcriptomic analysis. The authors identify PAK2 as a key fibrogenic kinase activated in FF and surrounding areas, and demonstrate that its inhibition attenuates fibrosis in a murine model, suggesting PAK2 as a promising therapeutic target.
引用
- Zhang X, Liu X, Noble PW, et al. From fibroblast foci to dense scars: PAK2-activated fibroblasts drive fibrosis progression in idiopathic pulmonary fibrosis. Eur Respir J. 2025. PMID: 41198410. doi:10.1183/13993003.01549-2025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。